Webinars Banner Image

Community Education Webinars

In partnership with The ALS Association, NEALS offers a variety of educational webinars for the ALS community.

Webinar topics include updates on clinical trials, best practices for clinical care, and current research efforts in ALS causes and treatments. Our webinars also offer participants the opportunity to ask questions directly of the experts running clinical trials and conducting research activities.
Neals logo
Cannabinoid use in ALS: Only symptom management or more? Screen Grab

Cannabinoid use in ALS: Only symptom management or more?

Please join us on March 23rd for a webinar discussion on cannabinoid use in ALS led by Drs. Mark Ware and Angela Genge from the Montreal Neurological Institute and Hospital. Dr. Ware will discuss the mechanism of action of cannabinoids,…

Actemra Study - Anti-inflammatory treatment for ALS Screen Grab

Actemra Study - Anti-inflammatory treatment for ALS

Dr. Shafeeq Ladha from Barrow Neurological Institute will review a clinical trial of Actemra in ALS patients. The rationale for using the drug and the role of inflammation in ALS progression will be discussed.

A User's Guide to Genetic Testing in ALS Screen Grab

A User's Guide to Genetic Testing in ALS

Genetic Counselor and Assistant Professor at The Ohio State University Medical Center, Jennifer Roggenbuck, will discuss genetic testing options in ALS. She will review our current understanding of ALS genetics, and outline points…

Opportunities and Tips for Raising ALS Awareness & Advocacy Screen Grab

Opportunities and Tips for Raising ALS Awareness & Advocacy

The November 14th webinar featured Mary Luper, a PALS who shared her experiences with ALS advocacy. Mary has learned a lot on the topic of advocacy over the past two years and hopes to share this knowledge with other PALS and CALS…

ALS Clinical Trial Pipeline Series - Fall 2016 Screen Grab

ALS Clinical Trial Pipeline Series - Fall 2016

Merit Cudkowicz, MD, MSc, Massachusetts General Hospital, will review the ALS clinical trial pipeline and answer questions about the current state of clinical research. This webinar will focus on current and upcoming ALS clinical…

C9: From ID (Identification) to Therapy Screen Grab

C9: From ID (Identification) to Therapy

Our expert panelists, Drs. Timothy Miller, Washington University, and Merit Cudkowicz, Massachusetts General Hospital, provide an update on the C9orf72 Natural History Study and discuss therapies in development for C9 patients. Steve…

Ibudilast trials in ALS Screen Grab

Ibudilast trials in ALS

Drs. Benjamin Brooks, Carolinas HealthCare System, and Nazem Atassi, Massachusetts General Hospital, provide an overview on two active, Phase 2 clinical trials of Ibudilast in subjects with ALS and discuss how their study teams are…

ALS Clinical Trial Pipeline Series - Spring 2016 Screen Grab

ALS Clinical Trial Pipeline Series - Spring 2016

Dr. Jeremy Shefner, Barrow Neurological Institute, describes the ALS clinical trial pipeline and answers questions about the current state of clinical research in ALS and motor neuron disease.